287 related articles for article (PubMed ID: 32279584)
1. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
Nascimento IS; Radin M; Gândara APR; Sciascia S; de Andrade DCO
Lupus; 2020 Jun; 29(7):676-685. PubMed ID: 32279584
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
3. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
Tonello M; Mattia E; Favaro M; Del Ross T; Calligaro A; Salvan E; Hoxha A; Fedrigo M; Ruffatti A
Thromb Res; 2019 May; 177():157-160. PubMed ID: 30903876
[TBL] [Abstract][Full Text] [Related]
4. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E
Front Immunol; 2021; 12():754469. PubMed ID: 34790198
[TBL] [Abstract][Full Text] [Related]
5. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
6. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
[TBL] [Abstract][Full Text] [Related]
7. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
9. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
Front Immunol; 2018; 9():2971. PubMed ID: 30619328
[No Abstract] [Full Text] [Related]
11. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
12. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
Ząbczyk M; Celińska-Löwenhoff M; Plens K; Iwaniec T; Musiał J; Undas A
J Thromb Haemost; 2019 Oct; 17(10):1746-1755. PubMed ID: 31220407
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
[TBL] [Abstract][Full Text] [Related]
14. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
[TBL] [Abstract][Full Text] [Related]
15. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
[TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
[TBL] [Abstract][Full Text] [Related]
17. Anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) increase the risk for thrombosis based on lupus anticoagulant positivity.
Zhang Y; Su Y; Guo H; Wang L; Li A; Wang C; Zhang J; Qiao R
Clin Biochem; 2023 Feb; 112():17-23. PubMed ID: 36535385
[TBL] [Abstract][Full Text] [Related]
18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
[TBL] [Abstract][Full Text] [Related]
20. Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
Canti V; Del Rosso S; Tonello M; Lucianò R; Hoxha A; Coletto LA; Vaglio Tessitore I; Rosa S; Manfredi AA; Castiglioni MT; Ruffatti A; Rovere-Querini P
J Rheumatol; 2018 Aug; 45(9):1263-1272. PubMed ID: 30008452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]